WO2023049693A3 - Formes posologiques pour l'administration d'un probiotique - Google Patents

Formes posologiques pour l'administration d'un probiotique Download PDF

Info

Publication number
WO2023049693A3
WO2023049693A3 PCT/US2022/076693 US2022076693W WO2023049693A3 WO 2023049693 A3 WO2023049693 A3 WO 2023049693A3 US 2022076693 W US2022076693 W US 2022076693W WO 2023049693 A3 WO2023049693 A3 WO 2023049693A3
Authority
WO
WIPO (PCT)
Prior art keywords
delivery
probiotic
dosage forms
infant
compositions
Prior art date
Application number
PCT/US2022/076693
Other languages
English (en)
Other versions
WO2023049693A2 (fr
Inventor
III Anthony R. Geonnotti
Patricia L. Golas
Richard BESINGI
Shoba Pillai
Original Assignee
Johnson & Johnson Consumer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/933,174 external-priority patent/US20230096810A1/en
Application filed by Johnson & Johnson Consumer Inc. filed Critical Johnson & Johnson Consumer Inc.
Priority to CA3233094A priority Critical patent/CA3233094A1/fr
Priority to CN202280064737.2A priority patent/CN118042943A/zh
Priority to JP2024518429A priority patent/JP2024533678A/ja
Priority to EP22813000.1A priority patent/EP4404771A2/fr
Priority to AU2022349055A priority patent/AU2022349055A1/en
Publication of WO2023049693A2 publication Critical patent/WO2023049693A2/fr
Publication of WO2023049693A3 publication Critical patent/WO2023049693A3/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pediatric Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des compositions et des procédés d'administration orale à un nourrisson d'Une composition contenant Bifidobacterium La composition peut être pré-chargée dans un sein artificiel ou une tétine ou placée directement sur celle-ci et peut également être appliquée directement sur la peau d'un soignant et/ou sur l'une des gencives, des dents ou des joues du nourrisson. Les compositions de l'invention se présentent sous forme d'une matière de remplissage de gel mou, de comprimés solubles ou désintégrables ou de formes pulvérulentes ou semi-solides et sont stables pendant au moins 24 mois lorsqu'elles sont stockées à 25 °C et avec 65 % d'humidité relative.
PCT/US2022/076693 2021-09-24 2022-09-20 Formes posologiques pour l'administration d'un probiotique WO2023049693A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA3233094A CA3233094A1 (fr) 2021-09-24 2022-09-20 Formes posologiques pour l'administration d'un probiotique
CN202280064737.2A CN118042943A (zh) 2021-09-24 2022-09-20 用于递送益生菌的剂型
JP2024518429A JP2024533678A (ja) 2021-09-24 2022-09-20 プロバイオティクスを送達するための剤形
EP22813000.1A EP4404771A2 (fr) 2021-09-24 2022-09-20 Formes posologiques pour l'administration d'un probiotique
AU2022349055A AU2022349055A1 (en) 2021-09-24 2022-09-20 Dosage forms for the delivery of a probiotic

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202163261581P 2021-09-24 2021-09-24
US63/261,581 2021-09-24
US17/933,174 US20230096810A1 (en) 2021-09-24 2022-09-19 Dosage forms for the delivery of a probiotic
US17/933,174 2022-09-19

Publications (2)

Publication Number Publication Date
WO2023049693A2 WO2023049693A2 (fr) 2023-03-30
WO2023049693A3 true WO2023049693A3 (fr) 2023-05-04

Family

ID=84362099

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2022/076693 WO2023049693A2 (fr) 2021-09-24 2022-09-20 Formes posologiques pour l'administration d'un probiotique

Country Status (1)

Country Link
WO (1) WO2023049693A2 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107259577A (zh) * 2017-07-25 2017-10-20 李立风 益生菌凝胶粒及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1958031A (en) 1931-04-27 1934-05-08 Eugene L Bresson Radio receiving system
KR100574506B1 (ko) 2004-02-26 2006-04-27 삼성전자주식회사 연산된 방위각의 오류여부를 표시하는 지자기센서 및 그방위각측정방법
IT1400821B1 (it) 2009-03-09 2013-07-02 Probiotical Spa Sospensione oleosa contenente batteri probiotici per uso pediatrico
US8198872B2 (en) 2009-03-10 2012-06-12 Honeywell International, Inc. Starter-generator with improved excitation
AU2011245768B2 (en) 2010-04-26 2015-04-09 Massey University Emulsion
TWI829098B (zh) 2015-01-02 2024-01-11 美商梅拉洛伊卡公司 細菌組成物
EP3427839B1 (fr) 2017-07-13 2020-12-02 Aptar Radolfzell GmbH Distributeur de liquide ayant une bouteille ventilée et une tête de distribution associée

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107259577A (zh) * 2017-07-25 2017-10-20 李立风 益生菌凝胶粒及其制备方法

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] MINTEL; 10 August 2021 (2021-08-10), ANONYMOUS: "ProbioMed Infant Dietary Supplement", XP093017073, retrieved from https://www.gnpd.com/sinatra/recordpage/8926943/ Database accession no. 8926943 *
DATABASE GNPD [online] MINTEL; 14 June 2019 (2019-06-14), ANONYMOUS: "Blueberry Probiotic Yoghurt", XP093017215, retrieved from https://www.gnpd.com/sinatra/recordpage/6629287/ Database accession no. 6629287 *
DATABASE GNPD [online] MINTEL; 31 July 2020 (2020-07-31), ANONYMOUS: "Vitamin D Drops", XP093017219, retrieved from https://www.gnpd.com/sinatra/recordpage/7991911/ Database accession no. 7991911 *
DATABASE GNPD [online] MINTEL; 6 July 2021 (2021-07-06), ANONYMOUS: "Multi-Vit + ProBio Gummies", XP093017208, retrieved from https://www.gnpd.com/sinatra/recordpage/8839399/ Database accession no. 8839399 *
JENNIFER T. SMILOWITZ ET AL: "Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial", BMC PEDIATRICS, vol. 17, no. 133, 30 May 2017 (2017-05-30), pages 1 - 11, XP055583343, DOI: 10.1186/s12887-017-0886-9 *

Also Published As

Publication number Publication date
WO2023049693A2 (fr) 2023-03-30

Similar Documents

Publication Publication Date Title
Att et al. Implant therapy to improve quality of life.
Guerra et al. Platform switch versus platform match in the posterior mandible–1‐year results of a multicentre randomized clinical trial
Hong Considerations in the pediatric population with cancer
Ettinger et al. Abutment tooth loss in patients with overdentures
Konstantinidis et al. Prospective evaluation of zirconia based tooth-and implant-supported fixed dental prostheses: 3-year results
Urdaneta et al. A screwless and cementless technique for the restoration of single‐tooth implants: a retrospective cohort study
Goldstein et al. Occlusal schemes for implant restorations: best evidence consensus statement
Chandu et al. Management of Xerostomia and Hyposalivation in Complete Denture Patients.
Sanz‐Martín et al. Randomized controlled clinical trial comparing two dental implants with different neck configurations
Ribeiro et al. Dental implant rehabilitation of a patient with down syndrome: a case report
Maló et al. Clinical outcomes in the presence and absence of keratinized mucosa in mandibular guided implant surgeries: a pilot study with a proposal for the modification of the technique.
Soardi et al. Clinical and radiographic evaluation of immediately loaded one-piece implants placed into fresh extraction sockets
Lombardo et al. Survival rates of ultra‐short (< 6 mm) compared with short locking‐taper implants supporting single crowns in posterior areas: a 5‐year retrospective study
Glibert et al. Six-Year Radiographic, Clinical, and Soft Tissue Outcomes of Immediately Loaded, Straight-Walled, Platform-Switched, Titanium-Alloy Implants with Nanosurface Topography.
Ter Gunne et al. Immediate and Early Loading of Two-Implant-Supported Mandibular Overdentures: Three-Year Report of Loading Results of a Single-Center Prospective Randomized Controlled Clinical Trial.
Huang et al. Barriers Related to Dental Implant Treatment Acceptance by Patients.
WO2023049693A3 (fr) Formes posologiques pour l&#39;administration d&#39;un probiotique
Kumar et al. Removable partial denture supported by implants with prefabricated telescopic abutments-a case report
Khazaie et al. Five‐Year Follow‐Up Treatment of an Ectodermal Dysplasia Patient with Maxillary Anterior Composites and Mandibular Denture: A Clinical Report
El-Amier et al. Effect of implant location on palateless complete overdenture retention: preliminary study
Payer et al. Immediate provisional restoration of XiVE® screw‐type implants in the posterior mandible
Shala et al. Evaluation of sensibility threshold for interocclusal thickness of patients wearing complete dentures
Anchieta et al. Root-supported overdenture as a prosthetic alternative for patients undergoing the transitional phase from partial to complete edentulism
Galganny-Almeida et al. The use of chlorhexidine varnishes in children: what is out there?
Antoun et al. Consecutive Case Series of Healed Single‐Molar Sites Immediately Restored with Wide‐Diameter Implants: A 1‐Year Evaluation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22813000

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 3233094

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2024518429

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 202280064737.2

Country of ref document: CN

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112024005539

Country of ref document: BR

WWE Wipo information: entry into national phase

Ref document number: AU2022349055

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2022813000

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2022813000

Country of ref document: EP

Effective date: 20240424

WWE Wipo information: entry into national phase

Ref document number: 11202402008Q

Country of ref document: SG

ENP Entry into the national phase

Ref document number: 2022349055

Country of ref document: AU

Date of ref document: 20220920

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 112024005539

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20240320